[1] CAREY EJ, ALI AH, LINDOR KD. Primary biliary cirrhosis[J].Lancet, 2015, 386(10003):1565-1575.
|
[2] BOONSTRA K, BEUERS U, PONSIOEN CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis:A systematic review[J]. J Hepatol, 2012, 56(5):1181-1188.
|
[3] Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on diagnosis and treatment of primary biliary cirrhosis(also known as primary bile cholangitis)(2015)[J]. J Clin Hepatol, 2015, 31(12):1980-1988.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015)[J].临床肝胆病杂志,2015, 31(12):1980-1988.
|
[4] LINDOR K, BOWLUS C, BOYER J, et al. Primary biliary cholangitis:2018 practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2019, 69(1):394-419.
|
[5] GATSELIS NK, ZACHOU K, LYGOURA V, et al. Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece[J]. Eur J Intern Med, 2017, 42:81-88.
|
[6] ZENG N, DUAN W, et al. Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region:A systematic review and meta-analysis[J]. Hepatol Int, 2019, 13:788.
|
[7] KOULENTAKI M, MANTAKA A, SIFAKI-PISTOLLA D, et al.Geoepidemiology and space-time analysis of primary biliary cirrhosis in Crete, Greece[J]. Liver Int, 2014, 34(7):e200-e207.
|
[8] SELMI C, MAYO MJ, BACH N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins:Genetics, epigenetics, and environment[J]. Gastroenterology, 2004, 127(2):485-492.
|
[9] ZHAO FC, ZHANG YP. Clinical characteristics of primary biliary cholangitis in 44 cases[J]. Xinjiang Med, 2019, 49(2):169-171,182.(in Chinese)赵凤丛,张永萍.44例原发性胆汁性胆管炎临床特征分析[J].新疆医学,2019, 49(2):169-171, 182.
|
[10] AL-HARTHY N, KUMAGI T, COLTESCU C, et al. The specificity of fatigue in primary biliary cirrhosis:Evaluation of a large clinic practice[J]. Hepatology, 2010, 52(2):562-570.
|
[11] YAMAGIWA S, KAMIMURA H, TAKAMURA M, et al. Autoantibodies in primary biliary cirrhosis:Recent progress in research on the pathogenetic and clinical significance[J]. World J Gastroenterol, 2014, 20(10):2606-2612.
|
[12] KOUROUMALIS E, SAMONAKIS D, VOUMVOURAKI A. Biomarkers for primary biliary cholangitis:Current perspectives[J]. Hepat Med, 2018, 10:43-53.
|
[13] FLOREANI A, FRANCESCHET I, CAZZAGON N. Primary biliary cirrhosis:Overlaps with other autoimmune disorders[J].Semin Liver Dis, 2014, 34(3):352-360.
|
[14] WANG L, ZHANG FC, CHEN H, et al. Connective tissue diseases in primary biliary cirrhosis:A population-based cohort study[J]. World J Gastroenterol, 2013, 19(31):5131-5137.
|
[15] HEATHCOTE J. The clinical expression of primary biliary cirrhosis[J]. Semin Liver Dis, 1997, 17(1):23-33.
|
[16] CAMACHO PM, PETAK SM, BINKLEY N, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2016[J]. Endocr Pract, 2016, 22(Suppl 4):1-42.
|
[17] GAO XS, ZHANG YN, LIU T, et al. Osteoporosis in patients with primary biliary cirrhosis[J/CD]. Chin J Liver Dis:Electronic Edition, 2018, 10(3):56-60.(in Chinese)高学松,张耀南,刘婷,等.原发性胆汁性肝硬化患者合并骨质疏松症临床研究[J/CD].中国肝脏病杂志(电子版),2018, 10(3):56-60.
|
[18] GLASS LM, SU GL. Metabolic bone disease in primary biliary cirrhosis[J]. Gastroenterol Clin North Am, 2016, 45(2):333-343.
|
[19] GUAÑABENS N, CERDÁD, MONEGAL A, et al. Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis[J]. Gastroenterology, 2010, 138(7):2348-2356.
|
[20] BUERBUHAN H, TANG XJ, LIU HH, et al. Correlation between dietary habits and incidence of anemia among Kazakh pregnant women in Altay, Xinjiang[J]. Chin Prev Med, 2016,17(2):154-156.(in Chinese)布尔布汗·哈什肯别克,汤雪娟,刘海湖,等.新疆阿勒泰地区哈萨克族孕妇饮食习惯与贫血发生率相关性研究[J].中国预防医学杂志,2016, 17(2):154-156.
|